While highly repetitive regions of the genome pose significant hurdles to reliable genetic analysis, their implications in disease are becoming clear. Asuragen is committed to providing clinical researchers with the kits needed to investigate the most compelling and challenging targets, including genes implicated in Alzheimer’s disease, ALS, FTD, Myotonic Dystrophy and Fragile X Syndrome.
Our AmplideX® PCR/CE FMR1*†, C9orf72* and TOMM40* RUO Kits overcome target complexity so you can focus on what matters most – scientific breakthroughs that drive better outcomes.
This technology has now expanded to address similarly challenging targets in the neurodegenerative space.
High-resolution genotyping of hexanucleotide repeats (GGGGCC) in the C9orf72 gene.
First clinical research tool that accurately resolves the poly-T polymorphism at the TOMM40 ‘523 locus with single base resolution.
*For Research Use Only. Not for use in diagnostic procedures. †CE-IVD. For US export only.
